CLINICAL_TRIALS
trial_result
· 2009-12-01
Clinical Trial Update: Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691 [Phase 1]
Summary
Pfizer's Phase 1 multiple-oral-dose study of PF-04878691 for hepatitis C has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED